These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 9708779
1. Fenoterol and asthma mortality. Kremer G, Disse B. Lancet; 1998 Aug 08; 352(9126):485-6. PubMed ID: 9708779 [No Abstract] [Full Text] [Related]
2. Fenoterol and asthma mortality. Lipworth B, Jackson C. Lancet; 1998 Aug 08; 352(9126):486-7. PubMed ID: 9708780 [No Abstract] [Full Text] [Related]
3. Fenoterol, asthma deaths, and asthma severity: confounding or confusion? Pearce N, Burgess C, Crane J, Beasley R. Thorax; 1997 Aug 08; 52(8):750-1. PubMed ID: 9337841 [No Abstract] [Full Text] [Related]
4. Beta-agonist therapy and asthma mortality in Japan. Beasley R, Nishima S, Pearce N, Crane J. Lancet; 1998 May 09; 351(9113):1406-7. PubMed ID: 9593418 [No Abstract] [Full Text] [Related]
5. Time trends in fenoterol and asthma deaths: optical illusion or reality check? Pearce N, Crane J, Beasley R. J Clin Epidemiol; 1998 Jul 09; 51(7):633-5. PubMed ID: 9674670 [No Abstract] [Full Text] [Related]
6. Epidemiologic studies of beta agonists and asthma deaths. Pearce N, Hensley MJ. Epidemiol Rev; 1998 Jul 09; 20(2):173-86. PubMed ID: 9919437 [No Abstract] [Full Text] [Related]
7. Risk of severe life threatening asthma. Barnes NC, Kuitert LM. Thorax; 1996 Nov 09; 51(11):1073. PubMed ID: 8958886 [No Abstract] [Full Text] [Related]
8. Withdrawal of fenoterol and the end of the New Zealand asthma mortality epidemic. Beasley R, Pearce N, Crane J, Burgess C. Int Arch Allergy Immunol; 1995 Nov 09; 107(1-3):325-7. PubMed ID: 7613161 [Abstract] [Full Text] [Related]
9. Optical illusions from visual data analysis: example of the New Zealand asthma mortality epidemic. Suissa S, Ernst P. J Clin Epidemiol; 1997 Oct 09; 50(10):1079-88. PubMed ID: 9368515 [Abstract] [Full Text] [Related]
10. Fenoterol and asthma mortality in New Zealand. Pearce N, Crane J, Burgess C, Grainger J, Beasley R. N Z Med J; 1990 Feb 28; 103(884):73-5. PubMed ID: 2308729 [No Abstract] [Full Text] [Related]
11. End of the New Zealand asthma mortality epidemic. Pearce N, Beasley R, Crane J, Burgess C, Jackson R. Lancet; 1995 Jan 07; 345(8941):41-4. PubMed ID: 7799709 [Abstract] [Full Text] [Related]
12. Fenoterol: enough is enough. Garrett JE, Lanes S, Kolbe J, Rea HH. N Z Med J; 1992 Oct 14; 105(943):414. PubMed ID: 1461600 [No Abstract] [Full Text] [Related]
13. Matching or selection bias in the fenoterol studies? Lanes SF. N Z Med J; 1992 Oct 14; 105(943):413-4. PubMed ID: 1461599 [No Abstract] [Full Text] [Related]
14. Fenoterol and asthma mortality. Crane J, Pearce N, Burgess C, Beasley R. N Z Med J; 1990 May 09; 103(889):225. PubMed ID: 2342700 [No Abstract] [Full Text] [Related]
15. Asthma deaths in New Zealand. Haas JF, Staudinger HW, Schuijt C. BMJ; 1992 Jun 20; 304(6842):1634. PubMed ID: 1628101 [No Abstract] [Full Text] [Related]
16. Fenoterol: the evidence leading to restriction of it use. Elwood JM. N Z Med J; 1990 Aug 22; 103(896):395-7. PubMed ID: 2200989 [No Abstract] [Full Text] [Related]
17. Risk of severe life threatening asthma and beta agonist type: an example of confounding by severity. Garrett JE, Lanes SF, Kolbe J, Rea HH. Thorax; 1996 Nov 22; 51(11):1093-9. PubMed ID: 8958891 [Abstract] [Full Text] [Related]
18. Asthma. Bronchodilators: new developments. Tattersfield AE. Br Med Bull; 1992 Jan 22; 48(1):190-204. PubMed ID: 1352168 [Abstract] [Full Text] [Related]
19. End of New Zealand asthma epidemic. Westendorp RG, Blauw GJ. Lancet; 1995 Apr 15; 345(8955):985. PubMed ID: 7715312 [No Abstract] [Full Text] [Related]
20. International trends in sales of inhaled fenoterol, all inhaled beta-agonists, and asthma mortality, 1970-1992. Lanes SF, Birmann B, Raiford D, Walker AM. J Clin Epidemiol; 1997 Mar 15; 50(3):321-8. PubMed ID: 9120532 [Abstract] [Full Text] [Related] Page: [Next] [New Search]